Apionex Pharma Private Limited, a active private limited company, was established on 05 October 2018 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U33209MH2018PTC315329. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
Its leadership includes Nirav Vinod Shah (Director), Nikita Nirav Shah (Director Appointed In Casual Vacancy), Chintal Tejas Laliwala (Additional Director). Past directors included Akash Mishra, Pratik Mohan Agnihotri. It holds ₹2.18 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1206, Plot No 856, Ghanshyam Enclave Link Road, Lalji Pada, Kandivali (West), Mumbai, Maharashtra, 400067.
U33209MH2018PTC315329
315329
05 October 2018
₹2.50 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Apionex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirav Vinod Shah | Director | 05 Oct 2018 | Current |
| Nikita Nirav Shah | Director Appointed In Casual Vacancy | 09 Dec 2024 | Current |
| Chintal Tejas Laliwala | Additional Director | 11 Dec 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jul 2024 | Past |
| Pramod Abcsdd | Director | 10 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apionex Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.77% increase. The company also saw a substantial improvement in profitability, with a 55.75% increase in profit. The company's net worth Soared by an impressive increase of 116.41%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Apionex Pharma had a public holding of 2.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2025 | Hdfc Bank Limited | ₹1.80 M | Open |
| 29 Jan 2022 | Hdfc Bank Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Apionex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Apionex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apionex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 1.80 M with Charge ID 101097517 was registered on 03 May 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited of Rs. 20.00 M registered on 29 Jan 2022 with Charge ID 100534981 was modified on 26 Dec 2024. was completed.
Chintal Tejas Laliwala was appointed as a Additional Director was appointed as a Additional Director on 11 Dec 2024 & has been associated with this company since 1 year 14 days . was recorded as a recent event.
Progress on Nikita Nirav Shah was appointed as a Director appointed in casual vacancy was appointed as a Director appointed in casual vacancy on 09 Dec 2024 & has been associated with this company since 1 year 16 days . was documented.
Apionex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Apionex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The CIN of Apionex Pharma Private Limited is U33209MH2018PTC315329.
Apionex Pharma Private Limited is headquartered at 1206, Plot No 856, Ghanshyam Enclave Link Road, Lalji Pada, Kandivali (West), Mumbai, Maharashtra, 400067.
Apionex Pharma Private Limited was incorporated on 05 October 2018.
The current directors of Apionex Pharma Private Limited are
The primary industry of Apionex Pharma Private Limited is Manufacturing.
Apionex Pharma Private Limited is unlisted.
The authorized capital of Apionex Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX